Global Research Initiative for Patients Screening on MASH
- Conditions
- fatty liverliver fibrosis10019654
- Registration Number
- NL-OMON56985
- Lead Sponsor
- Julius Clinical
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 1000
- 18-75 year old;
- new or established diagnosis of at least 1 of the following 4 conditions:
type 2 diabetes mellitus, obesity, arterial hypertension or metabolic syndrome
(diagnostic criteria defined in protocol).
- The patient is known with hepatitis B, C or HIV or any other liver condition
(like hemochromatosis, Wilson*s disease, sarcoidosis, etc);
- The patient is known with any other condition that may lead to liver fibrosis
or cirrhosis;
- The patient engages in (Excessive) alcohol use (defined as > 3 units/day in
males [30 grams/day] and > 2 units/day in females [20 grams/day]);
- The patient has a history or evidence of any other clinically significant
condition or planned or expected procedure that in the opinion of the
Investigator, may compromise the patient*s safety or ability to be included in
this study;
-The patient is an employee or contractor of the facility that is conducting
the study or is a family member of the Investigator, sub-Investigator, or any
Sponsor personnel;
- The patient is not able to understand the details of the protocol and/or is
not able to provide written informed consent;
- The patient is pregnant or breastfeeding.
- The patient underwent bariatric surgery in the last 12 months.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method